Pay in 4 interest-free payments of $5.65 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Remember that it is not some magic fix
While the therapy did not meet its primary endpoint of progression-free survival, it showed a notable improvement in overall survival: patients receiving IGV-001 had a median overall survival of 20.3 months compared with 14.0 months in the placebo arm, representing a 6.3-month increase
Viruses transmit mainly from person to person or between people who are in close contact with one another (within about 6 feet)
Factors That Could Slow Things Down Safety signals in larger trials
US$ 29.80
US$ 28.94
US$ 20.96
US$ 29.85
US$ 28.72
US$ 25.86
